Literature DB >> 27730579

Creating Heritable Mutations in Drosophila with CRISPR-Cas9.

Fillip Port1,2, Simon L Bullock3.   

Abstract

Reverse genetics-the creation of mutations in preselected target genes-has until recently been a bottleneck in many Drosophila projects. The advent of clustered, regularly interspaced, short palindromic repeat (CRISPR) genome engineering systems has transformed this situation. A short time after the in vitro demonstration of target site cleavage by the RNA-guided endonuclease CRISPR-associated nuclease 9 (Cas9) (Jinek et al., Science 337:816-821, 2012), hundreds of fly researchers are using CRISPR technology to generate loss-of-function mutant alleles in specific genes, as well as to create specific point mutations or tagged protein products. It appears that most target genes can be edited with remarkably high efficiency, with engineered strains often available a few weeks after conception of a project. Here, we provide a step-by-step protocol for creating loss-of-function mutations in Drosophila using transgenic Cas9 sources, which is based on optimized reagents and procedures that have been evaluated in our laboratory. We also provide guidance on extending this protocol to produce precise genomic alterations by homology-directed repair in the presence of a donor sequence. Additional information and updates are available from our website, www.crisprflydesign.org .

Entities:  

Keywords:  CRISPR-Cas9; Drosophila; Genome engineering; Genotyping; Indel; gRNA design and cloning

Mesh:

Substances:

Year:  2016        PMID: 27730579     DOI: 10.1007/978-1-4939-6371-3_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Retrovirus-like Gag Protein Arc1 Binds RNA and Traffics across Synaptic Boutons.

Authors:  James Ashley; Benjamin Cordy; Diandra Lucia; Lee G Fradkin; Vivian Budnik; Travis Thomson
Journal:  Cell       Date:  2018-01-11       Impact factor: 41.582

2.  Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis.

Authors:  Marion Miller; Aichun Chen; Vanessa Gobert; Benoit Augé; Mathilde Beau; Odile Burlet-Schiltz; Marc Haenlin; Lucas Waltzer
Journal:  PLoS Genet       Date:  2017-07-25       Impact factor: 5.917

Review 3.  Advances in Engineering the Fly Genome with the CRISPR-Cas System.

Authors:  Ethan Bier; Melissa M Harrison; Kate M O'Connor-Giles; Jill Wildonger
Journal:  Genetics       Date:  2018-01       Impact factor: 4.562

Review 4.  New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites.

Authors:  Manlio Di Cristina; Vern B Carruthers
Journal:  Parasitology       Date:  2018-02-21       Impact factor: 3.234

Review 5.  Impact of Drosophila Models in the Study and Treatment of Friedreich's Ataxia.

Authors:  Véronique Monnier; Jose Vicente Llorens; Juan Antonio Navarro
Journal:  Int J Mol Sci       Date:  2018-07-07       Impact factor: 5.923

6.  Improving one-step scarless genome editing in Drosophila melanogaster by combining ovoD co-CRISPR selection with sgRNA target site masking.

Authors:  Katharina J Götze; Achmed Mrestani; Paula Beckmann; Knut Krohn; Diana Le Duc; Akhil Velluva; Mathias A Böhme; Manfred Heckmann; Rami Abou Jamra; Johannes R Lemke; Hendrik Bläker; Nicole Scholz; Dmitrij Ljaschenko; Tobias Langenhan
Journal:  Biol Methods Protoc       Date:  2022-01-12

7.  The long noncoding RNA mimi scaffolds neuronal granules to maintain nervous system maturity.

Authors:  Dominika Grzejda; Jana Mach; Johanna Aurelia Schweizer; Barbara Hummel; Andrew Mischa Rezansoff; Florian Eggenhofer; Amol Panhale; Maria-Eleni Lalioti; Nina Cabezas Wallscheid; Rolf Backofen; Johannes Felsenberg; Valérie Hilgers
Journal:  Sci Adv       Date:  2022-09-28       Impact factor: 14.957

8.  The careful control of Polo kinase by APC/C-Ube2C ensures the intercellular transport of germline centrosomes during Drosophila oogenesis.

Authors:  Alexis Leah Braun; Francesco Meghini; Gema Villa-Fombuena; Morgane Guermont; Elisa Fernandez-Martinez; Zhang Qian; Maria Dolores Martín-Bermudo; Acaimo González-Reyes; David Moore Glover; Yuu Kimata
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

9.  FDA orphan drug designations for lysosomal storage disorders - a cross-sectional analysis.

Authors:  Sven F Garbade; Matthias Zielonka; Konstantin Mechler; Stefan Kölker; Georg F Hoffmann; Christian Staufner; Eugen Mengel; Markus Ries
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.